ArticleLasers in medical science2025
Comparative photobiomodulatory effects of 660 nm, 810 nm, and 940 nm diode lasers on platelet-rich fibrin: an ex vivo study on structural remodeling and VEGF/PDGF-BB release for enhanced periodontal healing.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Innovative photobiomodulation-enhanced T-PRF in posterior mandibular fractures: a randomized pilot study.BMC oral health · 2026Trial
- Effect of simultaneous application of low-level diode laser and leukocyte platelet-rich fibrin on gingival tissue healing: an in vitro investigation.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photobiomodulation (PBM) using diode lasers has emerged as a promising adjunct to enhance tissue regeneration. This ex vivo study evaluated the effects of three diode laser wavelengths (660 nm, 810 nm, 940 nm) on platelet-rich fibrin (PRF) structural remodeling and growth factors (vascular endothelial growth factor (VEGF), platelet-derived growth factor-BB (PDGF-BB)) release to optimize periodontal healing. Twenty PRF samples from healthy volunteers were divided into non-irradiated controls and subgroups irradiated at specific wavelengths. Structural changes were analyzed via scanning electron microscopy (SEM), while VEGF and PDGF-BB concentrations were quantified using enzyme-linked immunosorbent assay (ELISA). SEM revealed that 940 nm irradiation induced the most pronounced structural alterations, with 80% irregular fibrin fiber arrangement under low magnification, compared to smoother fibers in controls. Conversely, 660 nm irradiation significantly increased growth factor release, with PDGF-BB levels rising to 52.89 ± 6.70 pg/mL (p < 0.001 vs. controls: 40.17 ± 2.75) and VEGF to 52.30 ± 27.54 pg/mL (p = 0.021 vs. controls: 41.83 ± 16.52). Statistical analysis (one-way ANOVA, paired t-tests) confirmed wavelength-dependent effects, with 660 nm and 810 nm showing comparable efficacy (p = 0.999), while 940 nm underperformed in growth factor release. These findings suggest that 660 nm irradiation maximizes growth factor secretion for accelerated healing, whereas 940 nm enhances structural integrity via fibrin network remodeling. This wavelength-specific duality offers a strategic framework for clinicians to tailor PBM protocols-prioritizing either biochemical or structural outcomes-in periodontal regenerative therapies. Further in vivo studies are warranted to validate these translational potentials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.